- Home
- WT vs BCRX Comparison
WT vs BCRX Comparison
Compare WT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WT | BCRX |
|---|---|---|
| Founded | 1985 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.4B |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WT | BCRX |
|---|---|---|
| Price | $22.57 | $10.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $17.67 | ★ $20.82 |
| AVG Volume (30 Days) | 2.6M | ★ 3.4M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | 127.27 | ★ 381.40 |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $493,753,000.00 | $25,186,000.00 |
| Revenue This Year | $35.04 | N/A |
| Revenue Next Year | $8.68 | $12.55 |
| P/E Ratio | $157.14 | ★ N/A |
| Revenue Growth | ★ 15.43 | N/A |
| 52 Week Low | $10.69 | $6.00 |
| 52 Week High | $23.15 | $11.22 |
Technical Indicators
Market Signals| Indicator | WT | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 65.99 |
| Support Level | $16.06 | $8.79 |
| Resistance Level | $23.15 | $11.08 |
| Average True Range (ATR) | 0.96 | 0.44 |
| MACD | 0.20 | 0.12 |
| Stochastic Oscillator | 86.69 | 95.77 |
Price Performance
Historical ComparisonAbout WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.